The Future Of Europe's CBD Market Lies With Big Pharma And OTC Pathway

The "shakers and movers" in the European cannabidiol market in the next two to three years will be big pharma, says Irish synthetic CBD specialist Chanelle McCoy Health. With its purported health benefits, CBD will also need to go the way of OTC drugs, with medicinal claims supported by clinical trials, the firm predicts. 

CBD Molecule
• Source: Shutterstock

Big consumer health players will soon dominate the European cannabidiol food supplements market, predicts Irish generics specialists Chanelle McCoy Health Ltd.

“If you ask us who are going to be the shakers and movers in the European CBD market in the next two to three years, it will be big pharma,” Chanelle McCoy Health co-founder

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography